Penumbra Inc is a healthcare company based in the United States that specializes in developing and manufacturing medical devices for the neurovascular and peripheral vascular markets. The company has a low-risk ESG score of 19.8. Penumbra's innovative products are designed for specialist physicians and sold to hospitals. Its neurovascular product category is the main revenue driver, offering solutions for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tools. In the peripheral vascular business, Penumbra focuses on devices for peripheral embolization and thrombectomy. The majority of Penumbra's revenue comes from the United States.